Foundation Medicine and Natera Partner to Advance Personalized Cancer Monitoring
Go back to Foundation Medicine and Natera Partner to Advance Personalized Cancer Monitoring| (NASDAQ: NTRA) | Delayed: 272.31 +10.40 (3.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $261.91 | 52 Week High | $13.80 | |||
| Open | $265.00 | 52 Week Low | $6.52 | |||
| Day High | $274.86 | P/E | N/A | |||
| Day Low | $263.00 | EPS | $0.00 | |||
| Volume | 1,784,077 | |||||

